Information platform for Japanese Medicines

Index:: Categories Active ingredients Manufacturers Tags

Market information List of ethical pharmaceutical supply information

Sign up Log in

Sign up Log in

Index:: Categories Active ingredients
Manufacturers Tags

Market information List of ethical pharmaceutical supply information

Top
Agents affecting nervous system and sensory organs
Agents affecting central nervous system
Antiparkinsonian agents
Others
NEODOPASTON COMBINATION TABLETS L100

NEODOPASTON COMBINATION TABLETS L100

Manufacturer: DAIICHI SANKYO COMPANY, LIMITED.

Packages: 10 tablet × 100 sheet = 1,000 tablet; 21 tablet × 50 sheet = 1,050 tablet; 10 tablet × 10 sheet = 100 tablet; 1,000 tablet × 1 bag = 1,000 tablet

Tags: Brand

Different Standards/Packaging Product

10 tablet × 100 sheet = 1,000 tablet
21 tablet × 50 sheet = 1,050 tablet
10 tablet × 10 sheet = 100 tablet
1,000 tablet × 1 bag = 1,000 tablet

Check all

Detailed information

10 tablet × 100 sheet = 1,000 tablet

NEODOPASTON COMBINATION TABLETS L100

Branded Name: NEODOPASTON COMBINATION TABLETS L100
Generic Name: レボドパ・カルビドパ水和物（１）錠
Heat Number / Carved Seal: OHARA~100
Form / Color: - / -
Ministry of Health and Welfare Code: 1169101F1120
YJ Code: 1169101F1120
Manufacturer: DAIICHI SANKYO COMPANY, LIMITED.
MA holder: DAIICHI SANKYO COMPANY, LIMITED.
Restriction Information: -
Storage Condition: -
Cautions for Storage: -
Brand / Authorized Generic / Generic: Brand
Biological Origin / Biosimilar: No
Strength: -
Prescription Drug: Yes
Followed by Generic: available
Effective date: 000 00, 0000
Lot No.: 00000000
Lead time: X days

Created at

2021-09-02T02:30:16Z

Updated at

2024-10-22T05:10:02Z

21 tablet × 50 sheet = 1,050 tablet

NEODOPASTON COMBINATION TABLETS L100

Branded Name: NEODOPASTON COMBINATION TABLETS L100
Generic Name: レボドパ・カルビドパ水和物（１）錠
Heat Number / Carved Seal: OHARA~100
Form / Color: - / -
Ministry of Health and Welfare Code: 1169101F1120
YJ Code: 1169101F1120
Manufacturer: DAIICHI SANKYO COMPANY, LIMITED.
MA holder: DAIICHI SANKYO COMPANY, LIMITED.
Restriction Information: -
Storage Condition: -
Cautions for Storage: -
Brand / Authorized Generic / Generic: Brand
Biological Origin / Biosimilar: No
Strength: -
Prescription Drug: Yes
Followed by Generic: available
Effective date: 000 00, 0000
Lot No.: 00000000
Lead time: X days

Created at

2021-09-02T02:30:16Z

Updated at

2024-10-22T05:10:02Z

10 tablet × 10 sheet = 100 tablet

NEODOPASTON COMBINATION TABLETS L100

Branded Name: NEODOPASTON COMBINATION TABLETS L100
Generic Name: レボドパ・カルビドパ水和物（１）錠
Heat Number / Carved Seal: OHARA~100
Form / Color: - / -
Ministry of Health and Welfare Code: 1169101F1120
YJ Code: 1169101F1120
Manufacturer: OHARA Pharmaceutical Co.,Ltd.
MA holder: OHARA Pharmaceutical Co.,Ltd.
Restriction Information: -
Storage Condition: -
Cautions for Storage: -
Brand / Authorized Generic / Generic: Brand
Biological Origin / Biosimilar: No
Strength: -
Prescription Drug: Yes
Followed by Generic: available
Effective date: 000 00, 0000
Lot No.: 00000000
Lead time: X days

Created at

2021-09-02T02:53:17Z

Updated at

2024-10-22T05:10:02Z

1,000 tablet × 1 bag = 1,000 tablet

NEODOPASTON COMBINATION TABLETS L100

Branded Name: NEODOPASTON COMBINATION TABLETS L100
Generic Name: レボドパ・カルビドパ水和物（１）錠
Heat Number / Carved Seal: OHARA~100
Form / Color: - / -
Ministry of Health and Welfare Code: 1169101F1120
YJ Code: 1169101F1120
Manufacturer: OHARA Pharmaceutical Co.,Ltd.
MA holder: OHARA Pharmaceutical Co.,Ltd.
Restriction Information: -
Storage Condition: -
Cautions for Storage: -
Brand / Authorized Generic / Generic: Brand
Biological Origin / Biosimilar: No
Strength: -
Prescription Drug: Yes
Followed by Generic: available
Effective date: 000 00, 0000
Lot No.: 00000000
Lead time: X days

Created at

2021-09-02T02:53:17Z

Updated at

2024-10-22T05:10:02Z

Japanese notation

Product Name: ネオドパストン配合錠Ｌ１００
Name of Manufacturer: 第一三共
Name of MA Holder: 第一三共、大原薬品工業
Form / Color: 錠 / 薄紅

Alternative pharmaceuticals

*About alternative pharmaceuticals...This information is based on the active ingredients, dosage form, and specifications/units. It does not necessarily mean that the product is currently available.

No alternative pharmaceuticals found.

1. PRESCRIPTION

“NEODOPASTON COMBINATION TABLETS L100” is a prescription medicine (Rx) in Japan.

2. IMPORT(SUPPORTING) DOCUMENTS

Certificate of Origin (CoO), Patient Information Leaflet (PIL) and Summary of Product Characteristics (SmPC) of “NEODOPASTON COMBINATION TABLETS L100” are available.
*PIL and SmPC are written in Japanese.

3. Clinical trials

Search on-going Clinical Trials of “NEODOPASTON COMBINATION TABLETS L100” on International Clinical Trials Registry Platform (ICTRP) Search Portal provided by WHO.
https://apps.who.int/trialsearch/

4. Price

Offering price is based on Ex Works. Currency can be chosen USD, EUR or JPY.

5. Shipment

Please arrange delivery with your favorite couriers or forwarders.
Temperature controlled box and temperature logger is available. Please let us know if needed.

6. Our process

1. Upload your license and make an inquiry

Use the search bar on Synapse to search by the product's name, active ingredient, or manufacturer. You can also view medicines by therapeutic categories. Once on the product page, click on "Add to My List" to inform us of your preferences and details. The more information you provide, the better we can assist you. We also accept general inquiries on the Contact Us page. Please submit your license.
Submit your License.

2. Receive a quote

You will receive a detailed quote, which is the Ex Works price.

3. Place an order

You can order the required products based on the provided quote.

4. We send a Proforma Invoice and prepare for delivery.

Upon receiving your purchase order (PO), we will send you a Proforma Invoice with payment details. Once the payment is received, we will process your order. Our experienced sourcing and logistics team will procure your products and prepare for shipping.